dtgm fusion protein
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2000 (NCT00003840)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Granulocyte-macrophage colony-stimulating factorBINDING AGENT
CSF2 binding agent
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- diphtheria toxin
Oral
No
Parenteral
No
Topical
No
Also known as
- dtgm fusion protein
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00074750 | Phase 1 | Dec 1, 2003 | University of Texas at Houston, Wake Forest University |
| NCT00003840 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2000 | National Cancer Institute (NCI), Wake Forest University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Wake Forest University | Academic/Hospital | 2 | 1 | 2 | 2000 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2000 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2003 |
3 organizations
Page 1 / 1